| Rank | Logo | Name | Ticker | Revenue | Price | Today % | Country |
|---|---|---|---|---|---|---|---|
| 1 |
|
CVS Health | CVS | $386.64 B | $74.36 | 2.64% | USA |
| 2 |
|
Johnson & Johnson | JNJ | $90.62 B | $176.63 | 0.03% | USA |
| 3 |
|
Sinopharm | 1099.HK | $80.09 B | $2.36 | 0.43% | China |
| 4 |
|
Roche | ROG.SW | $69.07 B | $318.85 | 1.89% | Switzerland |
| 5 |
|
Pfizer | PFE | $63.83 B | $23.76 | 1.39% | USA |
| 6 |
|
Merck | MRK | $63.61 B | $77.94 | 2.18% | USA |
| 7 |
|
AbbVie | ABBV | $58.32 B | $218.91 | 0.49% | USA |
| 8 |
|
AstraZeneca | AZN | $56.50 B | $73.04 | 3.08% | UK |
| 9 |
|
Novartis | NVS | $55.18 B | $122.42 | 0.47% | Switzerland |
| 10 |
|
Eli Lilly | LLY | $53.25 B | $720.46 | 2.88% | USA |
| 11 |
|
Bayer | BAYN.DE | $50.82 B | $31.84 | 1.32% | Germany |
| 12 |
|
Sanofi | SNY | $47.83 B | $45.14 | 2.70% | France |
| 13 |
|
Bristol-Myers Squibb | BMY | $47.70 B | $43.26 | 2.05% | USA |
| 14 |
|
Novo Nordisk | NVO | $46.07 B | $56.65 | 3.56% | Denmark |
| 15 |
|
GlaxoSmithKline | GSK | $41.57 B | $39.50 | 1.68% | UK |
| 16 |
|
China Resources Pharmaceutical Group | 3320.HK | $35.30 B | $0.61 | 0.83% | Hong Kong |
| 17 |
|
Amgen | AMGN | $34.91 B | $272.36 | 2.46% | USA |
| 18 |
|
Takeda Pharmaceutical | TAK | $30.19 B | $14.70 | 1.70% | Japan |
| 19 |
|
Gilead Sciences | GILD | $28.86 B | $111.32 | 2.06% | USA |
| 20 |
|
Merck KGaA | MRK.DE | $23.40 B | $124.11 | 1.80% | Germany |
| 21 |
|
Teva Pharmaceutical Industries | TEVA | $16.62 B | $18.42 | 4.43% | Israel |
| 22 |
|
CSL | CSL.AX | $14.69 B | $129.63 | 0.33% | Australia |
| 23 |
|
Otsuka Holdings | 4578.T | $14.47 B | $53.52 | 1.44% | Japan |
| 24 |
|
Regeneron Pharmaceuticals | REGN | $14.21 B | $555.88 | 3.66% | USA |
| 25 |
|
Viatris | VTRS | $14.11 B | $9.44 | 2.73% | USA |
| 26 |
|
LabCorp | LH | $13.48 B | $275.76 | 1.29% | USA |
| 27 |
|
Vertex Pharmaceuticals | VRTX | $11.41 B | $377.80 | 0.31% | USA |
| 28 |
|
Astellas Pharma | 4503.T | $10.95 B | $11.12 | 0.51% | Japan |
| 29 |
|
Daiichi Sankyō | 4568.T | $10.94 B | $22.85 | 0.00% | Japan |
| 30 |
|
Baxter | BAX | $10.88 B | $21.76 | 3.55% | USA |
| 31 |
|
Sandoz Group | SDZ.SW | $10.38 B | $57.96 | 1.72% | Switzerland |
| 32 |
|
Biogen | BIIB | $9.99 B | $136.90 | 0.56% | USA |
| 33 |
|
Bausch Health | BHC | $9.85 B | $6.48 | 2.63% | Canada |
| 34 |
|
Zoetis | ZTS | $9.38 B | $139.45 | 1.57% | USA |
| 35 |
|
Grifols | GRFS | $8.23 B | $9.77 | 0.91% | Spain |
| 36 |
|
ICON plc | ICLR | $8.08 B | $164.49 | 1.79% | Ireland |
| 37 |
|
Lonza | LONN.SW | $7.27 B | $647.71 | 1.26% | Switzerland |
| 38 |
|
Chugai Pharmaceutical | 4519.T | $7.19 B | $44.16 | 2.54% | Japan |
| 39 |
|
UCB | UCB.VI | $6.40 B | $234.19 | 1.62% | Belgium |
| 40 |
|
Organon | OGN | $6.28 B | $10.14 | 2.64% | USA |
| 41 |
|
Sun Pharmaceutical | SUNPHARMA.NS | $6.25 B | $18.33 | 0.02% | India |
| 42 |
|
WuXi AppTec | 2359.HK | $5.95 B | $14.31 | 1.92% | China |
| 43 |
|
Huadong Medicine (HD Medicine) | 000963.SZ | $5.93 B | $5.92 | 0.73% | China |
| 44 |
|
Fosun Pharma | 600196.SS | $5.58 B | $4.25 | 0.13% | China |
| 45 |
|
Eisai | 4523.T | $5.06 B | $34.48 | 1.66% | Japan |
| 46 |
|
Incyte | INCY | $4.58 B | $81.70 | 2.93% | USA |
| 47 |
|
BeOne Medicines | ONC | $4.56 B | $326.90 | 0.89% | USA |
| 48 |
|
Elanco | ELAN | $4.48 B | $18.67 | 0.43% | USA |
| 49 |
|
CSPC Pharmaceutical Group Limited | 1093.HK | $4.44 B | $1.20 | 1.59% | China |
| 50 |
|
Galderma Group | GALD.SW | $4.44 B | $169.18 | 3.36% | Switzerland |
| 51 |
|
Galenica | GALE.SW | $4.34 B | $105.72 | 0.00% | Switzerland |
| 52 |
|
Perrigo | PRGO | $4.32 B | $21.04 | 1.64% | Ireland |
| 53 |
|
Jiangsu Hengrui Medicine | 600276.SS | $4.19 B | $10.14 | 3.08% | China |
| 54 |
|
Jazz Pharmaceuticals | JAZZ | $4.08 B | $127.43 | 1.67% | Ireland |
| 55 |
|
Nipro Corporation | 8086.T | $4.00 B | $10.30 | 0.58% | Japan |
| 56 |
|
Dr. Reddy's Laboratories | RDY | $3.92 B | $14.16 | 1.90% | India |
| 57 |
|
Sino Biopharmaceutical | 1177.HK | $3.86 B | $1.03 | 0.13% | China |
| 58 |
|
Aurobindo Pharma | AUROPHARMA.NS | $3.72 B | $12.36 | 0.56% | India |
| 59 |
|
Ipsen | IPN.PA | $3.71 B | $130.30 | 2.96% | France |
| 60 |
|
Lundbeck | HLUN-B.CO | $3.48 B | $7.11 | 0.44% | Denmark |
| 61 |
|
Ono Pharmaceutical | 4528.T | $3.43 B | $11.42 | 0.99% | Japan |
| 62 |
|
Cipla | CIPLA.NS | $3.21 B | $17.01 | 1.84% | India |
| 63 |
|
kyowa Kirin | 4151.T | $3.16 B | $15.46 | 0.24% | Japan |
| 64 |
|
BioNTech | BNTX | $3.12 B | $97.96 | 1.79% | Germany |
| 65 |
|
Hikma Pharmaceuticals | HIK.L | $3.12 B | $21.29 | 1.30% | UK |
| 66 |
|
United Therapeutics | UTHR | $3.07 B | $424.56 | 3.23% | USA |
| 67 |
|
BioMarin Pharmaceutical | BMRN | $3.06 B | $52.85 | 1.71% | USA |
| 68 |
|
Moderna | MRNA | $3.05 B | $24.90 | 3.79% | USA |
| 69 |
|
Argenx | ARGX | $3.05 B | $704.00 | 3.53% | Netherlands |
| 70 |
|
Shionogi | 4507.T | $2.97 B | $17.48 | 2.03% | Japan |
| 71 |
|
West Pharmaceutical | WST | $2.96 B | $253.45 | 2.50% | USA |
| 72 |
|
Amneal Pharmaceuticals | AMRX | $2.85 B | $9.54 | 1.80% | USA |
| 73 |
|
Recordati | REC.MI | $2.73 B | $59.25 | 3.06% | Italy |
| 74 |
|
Zydus Lifesciences | ZYDUSLIFE.NS | $2.69 B | $11.48 | 1.62% | India |
| 75 |
|
Lupin Limited | LUPIN.NS | $2.68 B | $22.12 | 1.38% | India |
| 76 |
|
Celltrion | 068270.KS | $2.68 B | $126.20 | 0.57% | S. Korea |
| 77 |
|
Swedish Orphan Biovitrum | SOBI.ST | $2.65 B | $29.24 | 0.07% | Sweden |
| 78 |
|
Tong Ren Tang | 600085.SS | $2.57 B | $4.79 | 0.78% | China |
| 79 |
|
WuXi Biologics | WXXWY | $2.55 B | $10.25 | 0.89% | China |
| 80 |
|
Clicks Group | CLS.JO | $2.54 B | $20.49 | 0.55% | South Africa |
| 81 |
|
Neurocrine Biosciences | NBIX | $2.50 B | $141.58 | 3.47% | USA |
| 82 |
|
Sarepta Therapeutics | SRPT | $2.48 B | $17.97 | 1.59% | USA |
| 83 |
|
Aspen Pharmacare | APN.JO | $2.47 B | $5.47 | 4.72% | South Africa |
| 84 |
|
Alnylam Pharmaceuticals | ALNY | $2.46 B | $449.80 | 1.87% | USA |
| 85 |
|
Richter Gedeon | RIG2.F | $2.46 B | $29.40 | 0.00% | Hungary |
| 86 |
|
Royalty Pharma | RPRX | $2.30 B | $35.16 | 1.71% | UK |
| 87 |
|
Medpace | MEDP | $2.23 B | $488.38 | 1.80% | USA |
| 88 |
|
Exelixis | EXEL | $2.23 B | $38.62 | 0.73% | USA |
| 89 |
|
Medios AG | ILM1.DE | $2.17 B | $15.57 | 0.91% | Germany |
| 90 |
|
Sumitomo Pharma | 4506.T | $2.14 B | $11.04 | 2.08% | Japan |
| 91 |
|
Santen Pharmaceutical | 4536.T | $2.06 B | $10.98 | 0.71% | Japan |
| 92 |
|
Mallinckrodt Pharmaceuticals | MNK | $1.93 B | $0.34 | 0.00% | UK |
| 93 |
|
Orion Corporation | ORNAV.HE | $1.85 B | $75.84 | 2.26% | Finland |
| 94 |
|
Rohto Pharmaceutical | 4527.T | $1.84 B | $17.04 | 1.01% | Japan |
| 95 |
|
Changchun High-Tech Industry | 000661.SZ | $1.84 B | $17.19 | 1.71% | China |
| 96 |
|
Biocon | BIOCON.NS | $1.82 B | $4.01 | 0.84% | India |
| 97 |
|
Zhifei Biological Products | 300122.SZ | $1.77 B | $2.95 | 1.22% | China |
| 98 |
|
PTC Therapeutics | PTCT | $1.76 B | $58.11 | 2.34% | USA |
| 99 |
|
Hansoh Pharma | 3692.HK | $1.68 B | $4.57 | 1.77% | China |
| 100 |
|
Towa Pharmaceutical | 4553.T | $1.55 B | $19.97 | 0.17% | Japan |
A snapshot of industry leaders at your fingertips. Explore top-performing companies from diverse sectors, compare their market standings, and discover trends shaping the business world — all in one place.